Cargando…
The Inhibition of SARS-CoV-2 and the Modulation of Inflammatory Responses by the Extract of Lactobacillus sakei Probio65
In the three years since the first outbreak of COVID-19 in 2019, the SARS-CoV-2 virus has continued to be prevalent in our community. It is believed that the virus will remain present, and be transmitted at a predictable rate, turning endemic. A major challenge that leads to this is the constant yet...
Autores principales: | Rather, Irfan A., Lew, Lee-Ching, Kamli, Majid Rasool, Hakeem, Khalid Rehman, Sabir, Jamal S. M., Park, Yong-Ha, Hor, Yan-Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787410/ https://www.ncbi.nlm.nih.gov/pubmed/36560517 http://dx.doi.org/10.3390/vaccines10122106 |
Ejemplares similares
-
Potential Adjuvant Therapeutic Effect of Lactobacillus plantarum Probio-88 Postbiotics against SARS-COV-2
por: Rather, Irfan A., et al.
Publicado: (2021) -
Effect of a bioactive product SEL001 from Lactobacillus sakei probio65 on gut microbiota and its anti-colitis effects in a TNBS-induced colitis mouse model
por: Rather, Irfan A., et al.
Publicado: (2020) -
Probiotic Lactobacillus sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model
por: Rather, Irfan A., et al.
Publicado: (2018) -
Lactiplantibacillus plantarum KAU007 Extract Modulates Critical Virulence Attributes and Biofilm Formation in Sinusitis Causing Streptococcus pyogenes
por: Rather, Irfan A., et al.
Publicado: (2022) -
Limosilactobacillus fermentum KAU0021 Abrogates Mono- and Polymicrobial Biofilms Formed by Candida albicans and Staphylococcus aureus
por: Rather, Irfan A., et al.
Publicado: (2023)